Date published: 2025-11-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Mystique Inhibitors

Mystique Inhibitors are a class of chemical compounds that specifically modulate the activity of the PDLIM2 gene. The PDLIM2 gene encodes a protein that belongs to the PDZ and LIM domain protein family, which plays a critical role in regulating cellular signaling pathways, especially those involved in cytoskeletal organization and transcriptional control. PDLIM2 is a key regulator of various cellular processes, including cell migration, differentiation, and the maintenance of cellular integrity. Mystique Inhibitors function by interacting with the molecular pathways controlled by PDLIM2, modulating the gene's activity without disrupting its core functions. These inhibitors are unique in their ability to target the LIM domain of the PDLIM2 protein, which is crucial for its scaffolding and signaling roles within the cell. By selectively binding to this region, Mystique Inhibitors alter protein-protein interactions mediated by PDLIM2, affecting its downstream signaling cascades.

The specificity of Mystique Inhibitors to PDLIM2 highlights their potential as research tools for studying the intricate cellular networks governed by this gene. PDLIM2's involvement in the regulation of both cytoskeletal dynamics and nuclear processes provides numerous avenues for exploration in the field of cellular biology. The inhibitors may be useful for examining how PDLIM2 influences cell adhesion, motility, and intracellular signaling networks. Additionally, because PDLIM2 is implicated in modulating transcription factors and cytoskeletal components, Mystique Inhibitors can serve as a molecular probe to further investigate the interactions between these essential cellular functions. Researchers studying cell signaling, protein networks, or gene regulation may find these inhibitors valuable for elucidating the mechanistic details of how PDLIM2 integrates various signaling pathways.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$36.00
$68.00
$107.00
$214.00
$234.00
$862.00
$1968.00
47
(1)

Curcumin, a compound in turmeric, is known to modulate numerous signaling molecules, potentially affecting PDLIM2-associated pathways.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$60.00
$185.00
$365.00
64
(2)

Resveratrol impacts various signaling pathways, including those related to inflammation and immune response, potentially influencing PDLIM2.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

This PI3K inhibitor could affect PDLIM2 functions indirectly through the PI3K/Akt pathway.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580, a p38 MAPK inhibitor, may indirectly affect PDLIM2 by altering stress response and inflammatory pathways.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

An inhibitor of MEK, PD98059 might impact PDLIM2's role by modulating the MAPK/ERK pathway.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

As a JNK inhibitor, SP600125 could indirectly influence PDLIM2-related cellular processes in the stress response pathway.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$61.00
$83.00
$349.00
155
(1)

This NF-κB inhibitor might have an indirect effect on PDLIM2, given PDLIM2’s role in NF-κB regulation.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

A proteasome inhibitor that could impact PDLIM2's function indirectly through the ubiquitin-proteasome pathway.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126, an inhibitor of MEK1/2, might affect PDLIM2 functions by influencing the MAPK/ERK pathway.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

As a PI3K inhibitor, wortmannin could indirectly affect PDLIM2 by altering the PI3K/Akt pathway.